References
Extracellular matrix graft for the surgical management of hurley stage iii hidradenitis suppurativa: a pilot case series
Abstract
Objective:
Surgical management of Hurley stage III hidradenitis suppurativa (HS) typically involves the excision of diseased tissue and subsequent reconstruction, potentially leading to complications or recurrence of the disease. This pilot case series sought to evaluate a decellularised ovine forestomach matrix (OFM) extracellular matrix (ECM) graft for soft tissue regeneration as part of surgical reconstruction of stage III HS of the axilla.
Method:
The prospective pilot case series involved six participants and a total of eight defects. The ECM graft was used either as a dermal substitute for a staged reconstruction (n=3 defects) or as an implant under a fasciocutaneous flap (n=5 defects) following wide excision of the diseased tissue. Results: In all cases complete healing was achieved, with no major surgical complications. When used as a dermal substitute the OFM graft was completely granulated within 2–4 weeks, with defects closing by secondary intention or following placement of a split-thickness skin graft. When used as an implant beneath a fasciocutaneous flap, healing of the surgical sites was observed after 1–3 months. At the long-term follow-up (3–12 months), all participants had excellent range of motion and none had reported disease recurrences.
Conclusion:
This pilot case series explored the implementation of an ECM graft as part of the surgical management of axilla Hurley stage III HS. Although the study had a limited number of participants, long-term outcomes were promising and suggest further studies are warranted.
Hidradenitis suppurativa (HS) is a debilitating, chronic inflammatory disease of the dermis.1 The causes of HS may be a combination of genetic, endocrine, environmental and microbial factors.2 Disease progression involves follicular occlusion caused by inflammation, hyperkeratosis and hyperplasia of sweat glands, and can lead to multiple abscesses and cysts in the affected area.2 Histological changes in HS versus normal tissue include a thickening of the epidermis, high cellular infiltration around hair follicles and disorganised collagen fibres with a decrease in collagen III.3 Overall, systemic inflammatory markers are higher in HS than non-HS dermal diseases, such as psoriasis.4
Treatment of HS depends on disease severity (i.e., Hurley stage I, II and III) and includes medical treatments (for example, antibiotics, steroids and anti-inflammatories), as well as surgical interventions to remove the diseased tissue.2 Recurrence is lower when therapeutic and surgical approaches are combined, compared with surgery alone.5 Surgical intervention for HS depends on the severity of the disease. In mild cases, local excision or deroofing of abscesses and sinuses may be sufficient.6 In severe cases of HS (for example, Hurley stage III) that include diffuse interconnecting tracts and abscesses across a large area, a significant surgical intervention is required, such as wide excision of the diseased tissue.6 Following wide excision, several reconstructive approaches are possible, including primary closure, healing via secondary intention, split-thickness skin grafting, local and free flaps.7 Recurrence rates after a wide excision appear lower than after local excision;5 however, the extent of tissue removal means that healing time is longer and complications more likely. Bouazzi et al.8 found that complication rates and recurrence rates remain relatively high at 25.1% and 14.0%, respectively. Ovadja et al.9 estimated recurrence rates for wide and partial excisions at 5% and 26%, respectively, from a meta-analysis of 125 articles. Complications associated with reconstruction after wide excision may be attributed to the poor quality of the underlying tissues (for example, fibrotic or inflamed tissue), potential for dead space between the advancing flap and underlying tissues, poor vascularity of the tissues, and associated patient comorbidities.
Register now to continue reading
Thank you for visiting Wound Central and reading some of our peer-reviewed resources for wound care professionals. To read more, please register today. You’ll enjoy the following great benefits:
What's included
-
Access to clinical or professional articles
-
New content and clinical updates each month